| 发明名称 |
PHARMACEUTICAL COMPOSITION OF IBRUTINIB |
| 摘要 |
The present invention provides a pharmaceutical composition comprising ibrutinib and CYP3A enzyme inhibitor, wherein the CYP3A enzyme inhibitor is ritonavir, ketoconazole or cobicistat. The present invention also provides a use of said pharmaceutical composition in the manufacture of anti-tumor medicaments. |
| 申请公布号 |
WO2017031914(A1) |
申请公布日期 |
2017.03.02 |
| 申请号 |
WO2016CN00443 |
申请日期 |
2016.08.10 |
| 申请人 |
BEIJING MEIBEITA DRUG RES CO LTD |
发明人 |
WANG, Jianming;YANG, Jiajun;WANG, Jinjing |
| 分类号 |
A61K31/519;A61K31/427;A61K31/496;A61K31/5377;A61P35/00 |
主分类号 |
A61K31/519 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
